Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 2,231.90
+28.50 (1.29%)
At close: Jul 31, 2026
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 22.53 billion as of July 31, 2026. Its market cap has increased by 31.40% in one year.
Market Cap
22.53B
Enterprise Value
22.76B
Revenue
4.10B
Ranking
n/a
PE Ratio
50.37
Stock Price
2,231.90
ChartMarket Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 22.53B, an increase of 2,359.66%. That is a compound annual growth rate of 44.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 22.53B | 44.08% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 60.48B |
| Innova Captab | 55.75B |
| Orchid Pharma | 50.04B |
| RPG Life Sciences | 45.78B |
| Solara Active Pharma Sciences | 24.74B |
| Indoco Remedies | 20.26B |
| Sakar Healthcare | 19.70B |
| Ind-Swift Laboratories | 19.45B |